<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
21:47
Iran and Oman have agreed on a shipping route through the Strait of Hormuz
21:38
919 primaries have not yet registered on Ghiseul.ro / Oana Gheorghiu: The deadline is August 25
21:20
The authorities of the Republic of Moldova and Ukraine are preparing anti-crisis measures following the decrease in the level of the Dniester River.
21:07
The third tunnel used for illegal migration, discovered at the border between Lithuania and Belarus
20:48
The National Environmental Guard imposed fines on the coast following 58 inspections. 13 activities were suspended.
See more news